CAMBRIDGE, Mass., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, today announced new translational ...
Sam Altman, CEO of OpenAI, has announced a significant shift in the organization’s focus. OpenAI, already confident in its ability to develop Artificial General Intelligence (AGI), is now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback